Thomas Englese - Sep 8, 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
Stock symbol
ELUT
Transactions as of
Sep 8, 2022
Transactions value $
-$34,514
Form type
4
Date filed
9/12/2022, 05:05 PM
Previous filing
Mar 10, 2022
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Options Exercise +15.4K +232.93% 22K Sep 8, 2022 Direct F1
transaction ELUT Class A Common Stock Tax liability -$34.5K -4.73K -21.49% $7.30* 17.3K Sep 8, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Restricted Stock Units Options Exercise $0 -15.4K -100% $0.00* 0 Sep 8, 2022 Class A Common Stock 15.4K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2 Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F3 The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.